An overview of allergic conjunctivitis

dc.contributor.authorSchellack, Natalie
dc.contributor.authorShirindza, N.
dc.contributor.authorMokoena, T.
dc.contributor.authorFlepisi, Brian Thabile
dc.contributor.emailnatalie.schellack@up.ac.zaen_US
dc.date.accessioned2022-10-14T06:49:19Z
dc.date.available2022-10-14T06:49:19Z
dc.date.issued2021
dc.description.abstractAllergic diseases affect many people across the globe. They significantly impact on the quality of life of the people who are affected, creating personal and economic predicaments. Some of the most commonly diagnosed allergic diseases include atopic dermatitis, rhinitis, allergic conjunctivitis and sinusitis. Allergic conjunctivitis is an allergic disease characterised by the inflammation of the conjunctiva caused by airborne allergens; it presents as itching, excessive lacrimation, discharge and pink eye. Usually it is associated with other allergic conditions such as allergic rhinitis and bronchial asthma. Allergic conjunctivitis is further divided into acute, seasonal allergic conjunctivitis (SAC), and perennial allergic conjunctivitis (PAC). Other conditions, such as eosinophilic oesophagitis, are on the rise and are being diagnosed across all continents except Africa. The diagnosis is primarily clinical. Antihistamines have been the mainstay of therapy for most allergic conditions, except for other conditions that require corticosteroids, or in severe allergic conditions such as anaphylaxis where antihistamines are ineffective as main therapy. It is important to consider first- versus secondgeneration options when treating allergic diseases, also bearing in mind the duration of therapy and any comorbid conditions that a patient might have. This article provides an overview of these conditions and their current management options.en_US
dc.description.departmentPharmacologyen_US
dc.description.librariandm2022en_US
dc.description.urihttp://www.sapj.co.za/index.php/SAPJen_US
dc.identifier.citationSchellack, N., Shirindza, N., Mokoena, T. et al. 'An overview of allergic conjunctivitis', South African Pharmaceutical Journal, vol. 88, no. 1. pp. 21-31.en_US
dc.identifier.issn2221-5875 (online)
dc.identifier.urihttps://repository.up.ac.za/handle/2263/87693
dc.language.isoenen_US
dc.publisherHealth and Medical Publishing Groupen_US
dc.rights© Medpharm Publications. This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License.en_US
dc.subjectAllergic diseaseen_US
dc.subjectAntihistamineen_US
dc.subjectAnaphylaxisen_US
dc.subjectAtopyen_US
dc.subjectAtopic marchen_US
dc.subjectRhinitisen_US
dc.subjectSinusitisen_US
dc.titleAn overview of allergic conjunctivitisen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Schellack_Overview_2021.pdf
Size:
295.08 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: